Skip to main content
. 2010 Spring;21(1):e28–e63. doi: 10.1155/2010/690654

Figure 2.

Figure 2

Model diagram (corresponding to Figure 1 in the main text) showing the different pathways of infection with treatment, emergence and transmission of resistant infection. Dashed arrows show the emergence of de novo resistance during treatment, and dashed boxes show symptomatic infections with resistance to oseltamivir, zanamivir, or both (cross-resistance).